Interleukin-6 and Tumor Growth Factor–β are Risk Factors for Idiopathic Epistaxis
File version
Author(s)
Golshiri-Isfahani, Ali
Fathollahi, Mahmood Sheikh
Rezayati, Mohammadtaghi
Bahramabadi, Reza
Afrooz, Mohammadreza
Asadikaram, Gholamreza
Kennedy, Derek
Arababadi, Mohammad Kazemi
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
Objective: To evaluate the serum levels of interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-α, tumor growth factor (TGF)-β, endothelin, and immunoglobulin (Ig)E in patients with idiopathic epistaxis, compared with healthy control individuals. Methods: Serum levels of IL-6, IL-8, TNF-α, TGF-β, endothelin, and IgE were evaluated in 110 patients with idiopathic epistaxis and 100 healthy controls using the enzyme-linked immunosorbent assay (ELISA) technique. Results: Serum levels of IL-6 (P <.001) and TGF-β (P = .001) were significantly increased in patients with idiopathic epistaxis, compared with controls. TNF-α serum levels were significantly increased in male patients, compared with female patients (P = .053). We observed decreased antihistamine levels and increased expression of TGF-β (P = .02) and TNF-α (P = .02), respectively. Conclusions: IL-6 and TGF-β appear to participate in the pathogenesis of idiopathic epistaxis. TNF-α may be considered a risk factor for male patients in developing epistaxis. Antihistamines may inhibit angiogenesis by decreasing expression of TGF-β and increasing expression of TNF-α.
Journal Title
Laboratory Medicine
Conference Title
Book Title
Edition
Volume
49
Issue
4
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Tumour immunology
Oncology and carcinogenesis
Science & Technology
Life Sciences & Biomedicine
Medical Laboratory Technology
cytokine
endothelin
Persistent link to this record
Citation
Rahmanzadeh-Shahi, S; Golshiri-Isfahani, A; Fathollahi, MS; Rezayati, M; Bahramabadi, R; Afrooz, M; Asadikaram, G; Kennedy, D; Arababadi, MK, Interleukin-6 and Tumor Growth Factor–β are Risk Factors for Idiopathic Epistaxis, Laboratory Medicine, 2018, 49 (4), pp. 329-341